5-HT₆ Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3739-3759
Author(s): Natasja M.W.J. de Bruin,Chris G Kruse

The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases

Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 1 Year: 2007 Page: 3-19
Author(s): M. D. Berry

Drug Design of GPCR Ligands Using Physicogenetics and Chemogenomics - Principles and Case Studies

Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1882-1901
Author(s): Thomas M. Frimurer, Thomas Hogberg

Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice

Journal: Current Drug Metabolism
Volume: 12 Issue: 7 Year: 2011 Page: 621-634
Author(s): Alberto Pilotto, Francesco Panza, Davide Seripa

Animal Models of Depressive Illness: The Importance of Chronic Drug Treatment

Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 171-203
Author(s): P. J. Mitchell, P. H. Redfern

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2411-2430
Author(s): Mak Adam Daulatzai

Fluoride Interactions: From Molecules to Disease

Journal: Current Signal Transduction Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 190-213
Author(s): Anna Strunecka, Jiri Patocka, Russell L. Blaylock, Niloufer J. Chinoy